Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Why GM is investing $918 million to build a gas-hungry V8 in 2023

    January 28, 2023

    General Motors donates $100,000 to Northwood for automotive camp for high school seniors

    January 28, 2023

    What is Kratom?Why are Louisiana authorities banning it? | | Local Politics

    January 28, 2023
    Facebook Twitter Instagram
    Trending
    • Why GM is investing $918 million to build a gas-hungry V8 in 2023
    • General Motors donates $100,000 to Northwood for automotive camp for high school seniors
    • What is Kratom?Why are Louisiana authorities banning it? | | Local Politics
    • To solve Ukraine’s problems, Russia turns to the masterminds of the war
    • These two FAANG stocks are ‘strong buys’ despite layoffs, earnings pressure
    • These money and investment tips can warm up your portfolio when stocks cool
    • Nasdaq bear market: Kathy Wood is still bullish on these three slumped growth stocks
    • US diplomatic missions to Middle East clouded by violence
    Facebook Twitter Instagram YouTube
    PayDay Loans All OnlinePayDay Loans All Online
    • Home
    • Earnings

      These two FAANG stocks are ‘strong buys’ despite layoffs, earnings pressure

      January 28, 2023

      American Riviera Bancorp Announces Fourth Quarter 2022 Earnings | Jobs

      January 28, 2023

      Tech Roundup: Microsoft, Intel Lead Latest Earnings Parade

      January 28, 2023

      Can I buy TSLA shares after earnings? Not so soon

      January 28, 2023

      Pacific Premier Bancorp (NASDAQ:PPBI) Reports Results $0.01 EPS Below Guidance

      January 28, 2023
    • FTA

      Government says Joe Biden was to blame for UK failing to keep trade deal promises

      January 28, 2023

      India-UAE trade gap widens to $5 billion after FTA

      January 28, 2023

      Oct. 28 and Jan. 15-Jan. 21 Arrest Reports – Shelby County Reporter

      January 27, 2023

      Free trade between India and the UK: an unfinished business

      January 27, 2023

      India-UAE trade deficit widens to $5 billion after FTA

      January 27, 2023
    • General

      General Motors donates $100,000 to Northwood for automotive camp for high school seniors

      January 28, 2023

      To solve Ukraine’s problems, Russia turns to the masterminds of the war

      January 28, 2023

      Dollar General will open its 19,000th store and donate $19,000 to nearby Royal Heights Elementary School.news

      January 28, 2023

      Dollar General Announces 19,000th Store Opening

      January 28, 2023

      Northwood University receives $100,000 from General Motors for high school car camp

      January 28, 2023
    • Investing

      Why GM is investing $918 million to build a gas-hungry V8 in 2023

      January 28, 2023

      These money and investment tips can warm up your portfolio when stocks cool

      January 28, 2023

      Nasdaq bear market: Kathy Wood is still bullish on these three slumped growth stocks

      January 28, 2023

      How microbusiness investments can yield big financial returns

      January 28, 2023

      Investing in a Whole Home Energy Audit

      January 28, 2023
    • Politics

      What is Kratom?Why are Louisiana authorities banning it? | | Local Politics

      January 28, 2023

      US diplomatic missions to Middle East clouded by violence

      January 28, 2023

      Finland, Sweden FM: NATO accession process not stopped

      January 28, 2023

      As mass shootings again draw public attention, states deepen their political divide on gun policies

      January 28, 2023

      Democrat Linda Lopez targeted.

      January 28, 2023
    • RWL

      Global Packaged Water Treatment System Industry Size, Shares,

      January 25, 2023

      Edendale women’s soccer team ‘shattered’

      January 25, 2023

      Purchased by Fusion Family Wealth LLC

      January 25, 2023

      Himachal

      January 22, 2023

      10वींनेशनलगतकगतक Result.

      January 21, 2023
    • Small Cap

      12 cash-rich small-cap stocks to invest in

      January 28, 2023

      A small steel company approves a stock split.Click here for recording date

      January 28, 2023

      Small textile stocks set record date for share buybacks, premium rises 33%

      January 28, 2023

      Small caps declare dividend of INR 20 per share, Scrip hits 52-week low

      January 28, 2023

      Over 50 small-cap stocks plunge 26% in this week’s market crash

      January 28, 2023
    PayDay Loans All OnlinePayDay Loans All Online
    Home » Analyst Expectations for Compass Therapeutics, Inc.’s 2027 Results (NASDAQ:CMPX)
    Earnings

    Analyst Expectations for Compass Therapeutics, Inc.’s 2027 Results (NASDAQ:CMPX)

    paydayloansallonline_110na0By paydayloansallonline_110na0January 21, 2023No Comments5 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Compass Therapeutics logo

    → Defy New Year’s instability with artificial intelligence (From Vantage Point)pixel

    Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Rating) – HC Wainwright analysts provide 2027 EPS estimates for Compass Therapeutics shares in a research note issued to investors on Wednesday, January 18 Did. HC Wainwright analyst J. Pantginis expects the company’s annual earnings to be $0.01 per share. HC Wainwright is rated Buy with a price target of $10.00. Compass Therapeutics’ current consensus estimate for annual earnings is $0.39 per share.

    Compass Therapeutics (NASDAQ:CMPX – Get Rating) last reported quarterly results on Wednesday, November 9th. The company reported his earnings per share (EPS) for the quarter ($0.12), missing consensus expectations ($0.11) ($0.01).

    Several other research firms have also recently published reports on CMPX. LADENBURG THALM/SH SH raised his price target on Compass Therapeutics stock to his $9.00 in a research note on Wednesday, November 16th. Raymond James raised Compass Therapeutics’ stock price target from his $5.00 to his $8.00 in a research report on Thursday, Nov. 10, giving the stock an “outperform” rating. Finally, EF Hutton Acquisition Co. I featured his Compass Therapeutics stake in a research report on Friday, Dec. 16. They set a Buy rating and set a company price target of $10.30. According to MarketBeat.com, Compass Therapeutics currently has an average Buy rating with a consensus target price of $9.33.

    Compass Therapeutics Stock Performance

    CMPX shares opened at $3.85 on Friday. The company has a 50-day moving average price of $4.74 and a 200-day moving average price of $3.55. The company has a market capitalization of $485.84 million, a P/E ratio of -8.93 and a beta of 1.35. Compass Therapeutics has a 52-week low of $1.25 and a 52-week high of $5.65.

    insider bet

    In another Compass Therapeutics news, COO Vered Bisker-Leib sold 14,929 shares in the company in a transaction on Tuesday, November 22nd. The shares sold for an average of $4.19 for a total of $62,552.51. Following the closing of the sale, the Chief Operating Officer now directly owns his 1,069,985 shares in the company, valued at $4,483,237.15. The transaction was disclosed in filings with the Securities and Exchange Commission and is available on his website at the SEC. In separate news, his COO Vered Bisker-Leib sold 14,929 shares of Compass Therapeutics in a deal on Tuesday, Nov. 22. The shares sold at an average price of $4.19, and the transaction totaled him $62,552.51. Following the closing of the transaction, the Chief Operating Officer now owns directly his 1,069,985 shares in the company, valued at his $4,483,237.15. The sale was disclosed in filings with the Securities and Exchange Commission, which can be accessed at this link. The director of Orbimed Advisors Llc also said he acquired 402,000 shares of Compass Therapeutics in a transaction on Tuesday, November 8th. The shares were acquired at an average price of $3.21 per share and an aggregate value of $1,290,420.00. Following the completion of the acquisition, the directors now directly own 15,219,994 shares of the Company’s stock valued at $48,856,180.74. For disclosure of this purchase, please click here. A corporate insider owns his 29.80% of the company’s shares.

    institution inflow and outflow

    Many large investors have recently changed positions in the company. Flagship Harbor Advisors LLC purchased new shares of Compass Therapeutics in the second quarter for a value of approximately $37,000. Jane Street Group LLC purchased a new stake in his Compass Therapeutics worth approximately $33,000 in the third quarter. The Bank of New York Mellon Corp bought a new stake in his Compass Therapeutics worth about $55,000 in the third quarter. Marshall Wace LLP increased his position in Compass Therapeutics by 118.4% in the third quarter. Marshall Weiss LLP now owns 51,816 shares of the company, valued at $117,000, after acquiring an additional 28,089 shares during this period. Finally, Renaissance Technologies LLC increased its position in Compass Therapeutics by 397.5% in the second quarter. Renaissance Technologies LLC now owns 66,165 shares of the company stock valued at $175,000 after acquiring an additional 52,865 shares during this period. 54.27% of the shares are owned by institutional investors.

    Compass Therapeutics Company Profile

    (get rating)

    Compass Therapeutics, Inc. is a biopharmaceutical company focused on clinical-stage oncology, working to develop antibody-based therapeutics to treat a variety of human diseases. The Company’s product candidates in clinical development include CTX-009, an investigational bispecific antibody that blocks the delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways. CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137.

    References

    Compass Therapeutics (NASDAQ:CMPX) earnings history and estimates

    This instant news alert was generated by Narrative Science Technology and MarketBeat financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Send any questions or comments about this story to contact@marketbeat.com.

    Listen to this before considering Compass Therapeutics.

    MarketBeat tracks Wall Street’s most acclaimed and top performing research analysts and the stocks they recommend to clients every day. MarketBeat identified 5 stocks top analysts are quietly whispering to clients to buy now before the broader market catches on…and Compass Therapeutics wasn’t on the list .

    Compass Therapeutics is currently rated as a ‘buy’ among analysts, but the top rated analysts believe these five stocks are better buys.

    See 5 stocks here

    A Beginner's Guide to Pot Stock Investing Cover



    Source link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    paydayloansallonline_110na0
    • Website

    Related Posts

    These two FAANG stocks are ‘strong buys’ despite layoffs, earnings pressure

    January 28, 2023

    American Riviera Bancorp Announces Fourth Quarter 2022 Earnings | Jobs

    January 28, 2023

    Tech Roundup: Microsoft, Intel Lead Latest Earnings Parade

    January 28, 2023

    Leave A Reply Cancel Reply

    Our Picks

    Why GM is investing $918 million to build a gas-hungry V8 in 2023

    January 28, 2023

    General Motors donates $100,000 to Northwood for automotive camp for high school seniors

    January 28, 2023

    What is Kratom?Why are Louisiana authorities banning it? | | Local Politics

    January 28, 2023

    To solve Ukraine’s problems, Russia turns to the masterminds of the war

    January 28, 2023
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    Investing

    Why GM is investing $918 million to build a gas-hungry V8 in 2023

    By paydayloansallonline_110na0January 28, 20230

    House car culture Why GM is investing $918 million to build a gas-hungry V8 in…

    General Motors donates $100,000 to Northwood for automotive camp for high school seniors

    January 28, 2023

    What is Kratom?Why are Louisiana authorities banning it? | | Local Politics

    January 28, 2023

    To solve Ukraine’s problems, Russia turns to the masterminds of the war

    January 28, 2023
    About Us

    This website provides information about FTA and other things. Keep Supporting Us With the Latest News and we Will Provide the Best Of Our To Makes You Updated All Around The World News. Keep Sporting US.

    Our Picks

    Noise-Cancelling Headphones For a Superb Music Experience

    January 15, 2020

    Harry Potter: 10 Things Dursleys That Make No Sense

    January 15, 2020

    Dubai-Based Yacht Company is Offering Socially-Distanced Luxury

    January 15, 2020

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    Facebook Twitter Instagram Pinterest
    • Home
    • DMCA
    • Privacy Policy
    • Contact us
    © 2023 paydayloansallonline. Designed by paydayloansallonline.

    Type above and press Enter to search. Press Esc to cancel.